Shares of Chipotle had their best day in more than four years. Despite the surge, the stock is still way off its all-time high of nearly $760. Jeff Bernstein, Senior Restaurant Analyst at Barclays, was with us to discuss whether the hiring of its new CEO will be enough to fuel a turnaround for Chipotle.
Chipotle tapped Taco Bell's CEO, Brian Niccols. Investors were on board with the move, sending shares soaring. Bernstein said it will take some time for consumers to jump on board. Chipotle is not a major media advertiser, so getting the new message across won't be immediate, the analyst adds.
During his time at Taco Bell, Mr. Niccol played a key role in bringing life back to the brand, bringing innovative food items to the menu. His marketing background helped get consumers excited about items such as Quesarito, Naked Chicken Chalupa and Nacho Fries. Bernstein said he expects to see some new product news at Chipotle, but acknowledges the assembly-line structure will keep them somewhat limited.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
